A single dose of psilocybin, the major hallucinogenic component in magic mushrooms, induces long-lasting decreases in anxiety and depression in patients diagnosed with life-threatening cancer according to a new study presented today at the annual meeting of the American College of Neuropsychopharmacology.
Patients who receive a cancer diagnosis often develop debilitating symptoms of anxiety and depression. Reports from the 1960s and 1970s suggest that hallucinogenic drugs such as LSD may alleviate such symptoms in cancer patients, but the clinical value of hallucinogenic drugs for the treatment of mood disturbances in cancer patients remains unclear. In this new study, Roland Griffiths and colleagues from the Johns Hopkins University School of Medicine investigated the effects of psilocybin on symptoms of anxiety and depression in individuals diagnosed with life-threatening cancer. Five weeks after receiving a dose of psilocybin sufficiently high to induce changes in perception and mystical-type experiences, patients reported significantly lower levels of anxiety and depression compared with patients that received a low dose of the drug. The positive effects on mood persisted in the patients at 6 month follow-up.
The authors suggest that a single dose of psilocybin may be sufficient to produce enduring decreases in negative mood in patients with a life-threatening cancer.
Read more: Active ingredient in magic mushrooms reduces anxiety and depression in cancer patients
The Latest on: Psilocybin
[google_news title=”” keyword=”psilocybin” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Psilocybin
- Oregon issues first license under psilocybin programon March 23, 2023 at 1:11 am
Oregon has issued its first license under its new system that offers controlled use of psilocybin to the public. The Oregon Health Authority announced Wednesday that it had issued a manufacturer ...
- OHA issues state’s first psilocybin business licenseon March 22, 2023 at 1:07 pm
Oregon Psilocybin Services, a branch of the Oregon Health Authority, announced on March 22 that it issued the state’s first psilocybin license. The completed psilocybin business application comes ...
- Oregon issues first psilocybin licenseon March 22, 2023 at 12:09 pm
PORTLAND, Ore. — The Oregon Health Authority (OHA) issued the state's first psilocybin license on Wednesday. This is part of the nation's first regulatory framework for psilocybin services. The ...
- Nevada Legislators File Psilocybin, MDMA Legalization Measureon March 22, 2023 at 11:19 am
Legislators in the state of Nevada have introduced a measure to legalize psilocybin and promote studies into the psychedelic while also encouraging research on MDMA. The measure, introduced by Senator ...
- Oregon Approves Nation’s First Psilocybin Grower License To Supply Psychedelic Service Centerson March 22, 2023 at 10:19 am
Oregon regulators have approved the nation’s first-ever psilocybin production license under a novel state-based regulatory framework for broad access to the psychedelic that voters approved in 2020.
- Oregon Psilocybin Services issues state’s first licenseon March 22, 2023 at 9:34 am
The Oregon Health Authority has issued the state’s first psilocybin license as part of the first regulatory framework of psilocybin services.
- Stop Buying Psilocybin Mushroom Chocolates from Randoson March 21, 2023 at 3:41 pm
You could be eating psilocybin mushrooms for self-knowledge, to feel one with the universe, or to see trees breathe like you did the first time you took them. Whatever the reason, you’re probably not ...
- Majority Of Americans Back Legalizing Psychedelics Therapy And Federally Decriminalizing Substances Like Psilocybin, Poll Findson March 21, 2023 at 5:50 am
A strong majority of Americans support legalizing and regulating psychedelics therapy, and most back federally decriminalizing substances like MDMA and psilocybin, according to a new poll. The survey ...
- Psychedelic Medicine PAC seeks to elect leaders who support pro-psilocybin reformson March 20, 2023 at 5:15 pm
A political action committee (PAC) created to advocate for psychedelic medicine use in the country aims to elect leaders to support pro-psilocybin reforms. NBC News reported Monday that the newly ...
- As Oregon’s first psilocybin facilitators graduate, an untested industry awaitson March 20, 2023 at 7:33 am
On Sunday, Aleks Taylor became one of the first official psilocybin facilitation graduates in Oregon’s fledgling psilocybin industry. But it’s not clear when Taylor — or any of the other ...
via Bing News